130 related articles for article (PubMed ID: 8927422)
21. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
[TBL] [Abstract][Full Text] [Related]
22. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
23. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A
Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772
[TBL] [Abstract][Full Text] [Related]
24. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
25. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
[TBL] [Abstract][Full Text] [Related]
26. Correlation between DNA content and p53 deletion in colorectal cancer.
Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
[TBL] [Abstract][Full Text] [Related]
27. Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions.
Connelly JH; Robey-Cafferty SS; Cleary KR
Arch Pathol Lab Med; 1991 Oct; 115(10):1022-5. PubMed ID: 1654871
[TBL] [Abstract][Full Text] [Related]
28. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas.
Kubota K; Akasu T; Fujita S; Sugihara K; Moriya Y; Yamamoto S
Hepatogastroenterology; 2004; 51(55):142-6. PubMed ID: 15011850
[TBL] [Abstract][Full Text] [Related]
29. Pathological features of mucinous carcinoma of the breast are favourable for breast-conserving therapy.
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Nakahara S; Katsumoto F; Toyoshima S
Eur J Surg Oncol; 2001 Aug; 27(5):459-63. PubMed ID: 11504516
[TBL] [Abstract][Full Text] [Related]
30. HATH1 expression in mucinous cancers of the colorectum and related lesions.
Park ET; Oh HK; Gum JR; Crawley SC; Kakar S; Engel J; Leow CC; Gao WQ; Kim YS
Clin Cancer Res; 2006 Sep; 12(18):5403-10. PubMed ID: 17000673
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
[TBL] [Abstract][Full Text] [Related]
33. [Synchronous and metachronous colorectal cancers: a case series contribution].
Lucci S; Mascagni D; Rivolta R; Arcieri S; Candioli S; Manigrasso A; Papetti MT; Cerutti L; Torretta A; Di Matteo FM; Zaccagnino P
G Chir; 1999; 20(11-12):461-9. PubMed ID: 10645062
[TBL] [Abstract][Full Text] [Related]
34. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological studies and patterns of recurrence of mucinous colorectal carcinoma with curative resection].
Higuchi T; Kobayashi H; Ishikawa T; Ishiguro M; Iida S; Uetake H; Enomoto M; Sugihara K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2560-2. PubMed ID: 21224639
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite instability is associated with the histological features of the tumor in nonfamilial colorectal cancer.
Risio M; Reato G; di Celle PF; Fizzotti M; Rossini FP; Foà R
Cancer Res; 1996 Dec; 56(23):5470-4. PubMed ID: 8968103
[TBL] [Abstract][Full Text] [Related]
37. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of mucinous component in colorectal carcinoma.
Papadopoulos VN; Michalopoulos A; Netta S; Basdanis G; Paramythiotis D; Zatagias A; Berovalis P; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s123-5. PubMed ID: 15655594
[TBL] [Abstract][Full Text] [Related]
39. Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour.
Nagtegaal I; Gaspar C; Marijnen C; Van De Velde C; Fodde R; Van Krieken H
J Pathol; 2004 Oct; 204(2):183-92. PubMed ID: 15378567
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
